VRAYLAR is a prescription medicine used in adults: along with antidepressant medicines to treat major depressive disorder (MDD) for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder. to treat depressive episodes that happen with bipolar I (dipolar depression)

Not approved for use by anyone younger than 18 years old. Hypersensitivity reactions have been reported. Vraylar should not be taken by people who are allergic to any ingredients in the product. Vraylar may potentially harm an unborn baby.

SSRIs are antidepressants that are used to treat depression and anxiety disorders, among other uses. Vraylar is a kind of drug called an atypical antipsychotic. Vraylar does have some similar effects to an antidepressant and can be used to treat depression.

For depressive episodes associated with bipolar I disorder, three studies showed Vraylar was significantly superior to placebo at the end of week 6 using the MADRAS total score.

VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*

VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*

In 6- and 8-week studies†, adults, on average, experienced improvement in their overall depression symptoms after adding VRAYLAR to their antidepressant vs an antidepressant alone.

Vraylar User Reviews & Ratings. Vraylar has an average rating of 5.7 out of 10 from a total of 432 reviews on Drugs.com. 45% of reviewers reported a positive experience, while 38% reported a negative experience.

Within the first 1-2 weeks hallucinations, disorganized thinking and delusions may improve. After 1-2 weeks patients may feel more motivated and have a greater desire to be around other people.

For depressive episodes associated with bipolar I disorder, three studies showed Vraylar was significantly superior to placebo at the end of week 6 using the MADRAS total score.

VRAYLAR is a prescription medicine used in adults: along with antidepressant medicines to treat major depressive disorder (MDD) for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder. to treat depressive episodes that happen with bipolar I (dipolar depression)

Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms* Treat mixed episodes (symptoms of depression and mania at the same time)* Reduce the overall severity of the condition.